In gastric adenocarcinoma, downregulation of GALNT2 increased the cell proliferation, migration, invasion and tumor metastasis by increasing the phosphorylation of hepatocyte growth factor receptor (MET: a receptor tyrosine kinase like IGF-l) and decreasing the expression of the Tn antigen on MET [33]. Here, MET is linked to gastric adenocarcinoma.